PetMed Express, Inc. (PETS)

NasdaqGS: PETS · 即時價格 · USD

1.65

-0.05 (-2.94%)

收盤價： Sep 11, 2026, 3:59 PM

1.68

+1.82%

盤後: 7:30 PM

提醒

Alert

股價、關鍵數字和最新消息，都在這一頁。

-2.94% (1D)

買價	1.22
市值	35.8M
營收 (ttm)	169M
淨利（ttm）	-29.3M
	0.79
	-1.37
	n/a
	-55
P/B (ttm)	1.51
P/S (ttm)	0.21
財報日期	Oct 30, 2023

賣價	2.16
成交量	37,087
20 日平均成交量	638,038
開盤價	1.71
前收盤價	1.70
當日區間	1.65 - 1.75
52 週範圍	1.57 - 4.10
分析師	n/a
目標價	2.15 (30.3%)
股利	n/a
除息日	Aug 11, 2023

關於 PETS

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; ...

[閱讀更多]

產業 Pharmaceutical Retailers

類股 Healthcare

IPO 日期 Apr 26, 1999

員工 189

證券交易所 NasdaqGS

股票代號 PETS

網站 https://www.1800petmeds.com

完整的公司簡介

財務表現

PetMed Express 在 2026 年的營收為 179.02M，較前一年的 274.1M 減少 -34.69%。淨利為 -57.29M，較前期增加 667.5%。

財務報表

分析師預測

根據 1 位分析師的評等，PETS 的平均評等為「null」。12 個月目標價為 2.15，較最新價格有 30.3% 的上漲空間。

股票預測

財報驚奇

PetMed Express 已於 Aug 13, 2026 公布季度財報：

營收為 $41.02M 低於預期 $0, 年增 -19.86% 下滑.
每股盈餘為 -0.28 低於預期 -0.40, 年增 83.03% 成長.

下次財報發布

PetMed Express, Inc. 的下次財報預計於 Oct 30, 2023, 收盤後。
分析師預估營收 ... 升級

價格為何變動

新聞動態

3 週前 · Motley Fool

PetMed Express (PETS) Q1 2027 Earnings Call Transcript

Management evaluates $3-per-share offer while pursuing partnerships and operational improvements.

4 週前 · Zacks

PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y

PETS' fiscal first-quarter 2027 sales decline year over year, but lower costs, stronger recurring sales and new partnerships offer signs of progress.

1 月前 · GuruFocus.com

PetMed Express Inc (PETS) (Q1 2027) Earnings Call Highlights: Narrowing Losses and Strategic ...

PetMed Express narrows net loss to $6.1 million while expanding recurring revenue to 61.5% of sales and launching key partnerships despite a 19.9% revenue decline.

1 月前 · Moby

PetMed Express, Inc. Q1 2027 Earnings Call Summary

Moby summary of PetMed Express, Inc.'s Q1 2027 earnings call

1 月前 · Zacks

PetMed (PETS) Reports Q1 Loss, Misses Revenue Estimates

PetMed (PETS) delivered earnings and revenue surprises of -333.33% and -20.64%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

第 1 頁，共 2 頁

PetMed Express, Inc. (PETS)